Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Guiu

Showing results (191-200 of 241) with videos related to

Pageof 25
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 28, 2014
Predictive factors of transarterial chemoembolisation toxicity in unresectable hepatocellular carcinomaMathieu Boulin, Héloïse Adam, Boris Guiu, et al.
European Radiology|November 22, 2011
Prediction for steatosis in type-2 diabetes: clinico-biological markers versus 1H-MR spectroscopyBoris Guiu, Elodie Crevisy-Girod, Christine Binquet, et al.
Cancers|October 13, 2021
Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular CarcinomaMarie Cantaloube, Florence Castan, Morgane Creoff, et al.
The Oncologist|January 8, 2011
Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agentsSylvain Ladoire, Franck Bonnetain, Mélanie Gauthier, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 13, 2011
PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetesJean M Petit, Boris Guiu, David Masson, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2011
Randomised controlled trial of lipiodol transarterial chemoembolisation with or without amiodarone for unresectable hepatocellular carcinomaMathieu Boulin, Anne Ciboulet, Boris Guiu, et al.
Journal of Hepatology|December 25, 2019
Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCsAnita Paisant, Valérie Vilgrain, Jérémie Riou, et al.
Hepatology Communications|August 6, 2022
Non-transplantable recurrence after percutaneous thermal ablation of ≤3-cm HCC: Predictors and implications for treatment allocationCecilia Gozzo, Margaux Hermida, Astrid Herrero, et al.
BMC Cancer|December 31, 2013
Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levelsStefano Kim, Erion Dobi, Marine Jary, et al.
Clinics and Research in Hepatology and Gastroenterology|August 1, 2021
Non-invasive diagnosis and follow-up of benign liver tumoursJean-Charles Nault, Jean-Frédéric Blanc, Lucile Moga, et al.
Pageof 25

Showing results (191-200 of 241) with videos related to

Sort By:
Pageof 25
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 28, 2014
Predictive factors of transarterial chemoembolisation toxicity in unresectable hepatocellular carcinomaMathieu Boulin, Héloïse Adam, Boris Guiu, et al.
European Radiology|November 22, 2011
Prediction for steatosis in type-2 diabetes: clinico-biological markers versus 1H-MR spectroscopyBoris Guiu, Elodie Crevisy-Girod, Christine Binquet, et al.
Cancers|October 13, 2021
Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular CarcinomaMarie Cantaloube, Florence Castan, Morgane Creoff, et al.
The Oncologist|January 8, 2011
Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agentsSylvain Ladoire, Franck Bonnetain, Mélanie Gauthier, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 13, 2011
PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetesJean M Petit, Boris Guiu, David Masson, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2011
Randomised controlled trial of lipiodol transarterial chemoembolisation with or without amiodarone for unresectable hepatocellular carcinomaMathieu Boulin, Anne Ciboulet, Boris Guiu, et al.
Journal of Hepatology|December 25, 2019
Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCsAnita Paisant, Valérie Vilgrain, Jérémie Riou, et al.
Hepatology Communications|August 6, 2022
Non-transplantable recurrence after percutaneous thermal ablation of ≤3-cm HCC: Predictors and implications for treatment allocationCecilia Gozzo, Margaux Hermida, Astrid Herrero, et al.
BMC Cancer|December 31, 2013
Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levelsStefano Kim, Erion Dobi, Marine Jary, et al.
Clinics and Research in Hepatology and Gastroenterology|August 1, 2021
Non-invasive diagnosis and follow-up of benign liver tumoursJean-Charles Nault, Jean-Frédéric Blanc, Lucile Moga, et al.
Pageof 25